Literature DB >> 2497859

Determinants of bone density in normal women: risk factors for future osteoporosis?

J C Stevenson1, B Lees, M Devenport, M P Cust, K F Ganger.   

Abstract

Postmenopausal osteoporosis is an important public health problem in developed countries. Preventive treatment might effect a large reduction in the incidence, but this needs to be applied selectively to those women at increased risk. Loss of bone density results in an increased risk of fractures in the classical sites of vertebrae and proximal femur. A cross sectional study of bone density measurements was carried out in these sites in British women with a modern, precise densitometric technique. Possible predictors and risk factors for bone density were assessed in these women. Bone density was measured by dual photon absorptiometry in 284 apparently healthy women volunteers aged 21 to 68. The values obtained were similar to those obtained from equivalent studies performed in women in the United States. Peak adult bone density had been attained soon after the end of linear skeletal growth. Thereafter there was some decline with age in the proximal femur, but the major fall in bone density in all sites was related to the menopause. Other factors decreasing bone density, and hence increasing risk for osteoporosis, such as low body weight, alcohol and cigarette consumption, nulliparity, lack of previous use of oral contraceptives, and lack of regular exercise, seemed to be important. None, however, could predict satisfactorily women at future risk for osteoporosis. Direct measurements of bone density in the clinically relevant sites are necessary to determine which women should received preventive treatment for postmenopausal osteoporosis. This would help make such treatment more cost effective.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2497859      PMCID: PMC1836226          DOI: 10.1136/bmj.298.6678.924

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


  24 in total

1.  Alcohol-related skeletal disorders.

Authors:  P D Saville
Journal:  Ann N Y Acad Sci       Date:  1975-04-25       Impact factor: 5.691

2.  Menopausal bone loss and estrogen replacement.

Authors:  S Meema; H E Meema
Journal:  Isr J Med Sci       Date:  1976-07

3.  Osteoporosis of the slender smoker. Vertebral compression fractures and loss of metacarpal cortex in relation to postmenopausal cigarette smoking and lack of obesity.

Authors:  H W Daniell
Journal:  Arch Intern Med       Date:  1976-03

4.  Genetic factors in determining bone mass.

Authors:  D M Smith; W E Nance; K W Kang; J C Christian; C C Johnston
Journal:  J Clin Invest       Date:  1973-11       Impact factor: 14.808

5.  Effect of alcohol ingestion on bone and mineral metabolism in rats.

Authors:  D T Baran; S L Teitelbaum; M A Bergfeld; G Parker; E M Cruvant; L V Avioli
Journal:  Am J Physiol       Date:  1980-06

6.  Long-term prevention of postmenopausal osteoporosis by oestrogen. Evidence for an increased bone mass after delayed onset of oestrogen treatment.

Authors:  R Lindsay; D M Hart; J M Aitken; E B MacDonald; J B Anderson; A C Clarke
Journal:  Lancet       Date:  1976-05-15       Impact factor: 79.321

7.  Evidence of a toxic effect of ethanol on bone in rats.

Authors:  T C Peng; S C Garner; G D Frye; M A Crenshaw
Journal:  Alcohol Clin Exp Res       Date:  1982       Impact factor: 3.455

8.  Bone mineral content of the lumbar spine in normal and osteoporotic women: cross-sectional and longitudinal studies.

Authors:  B Krølner; S Pors Nielsen
Journal:  Clin Sci (Lond)       Date:  1982-03       Impact factor: 6.124

9.  Differential effects of endocrine dysfunction on the axial and the appendicular skeleton.

Authors:  E Seeman; H W Wahner; K P Offord; R Kumar; W J Johnson; B L Riggs
Journal:  J Clin Invest       Date:  1982-06       Impact factor: 14.808

10.  Identification of alcohol abuse: thoracic fractures on routine chest X-rays as indicators of alcoholism.

Authors:  Y Israel; H Orrego; S Holt; D W Macdonald; H E Meema
Journal:  Alcohol Clin Exp Res       Date:  1980-10       Impact factor: 3.455

View more
  86 in total

Review 1.  Hormone replacement therapy in postmenopausal women with diabetes mellitus: a risk-benefit assessment.

Authors:  B Andersson
Journal:  Drugs Aging       Date:  2000-11       Impact factor: 3.923

2.  Predicting the effects of estrogen replacement therapy on lumbar bone mineral density in oophorectomized women: analysis of a 10-year longitudinal study.

Authors:  Hideaki Nagata; Masahiro Nozaki; Hitoo Nakano
Journal:  Osteoporos Int       Date:  2003-10-08       Impact factor: 4.507

Review 3.  Osteoporosis: whose problem is it?

Authors:  A D Woolf
Journal:  Ann Rheum Dis       Date:  1992-01       Impact factor: 19.103

Review 4.  A risk-benefit assessment of estrogen therapy in postmenopausal women.

Authors:  M P Cust; K F Gangar; T C Hillard; M I Whitehead
Journal:  Drug Saf       Date:  1990 Sep-Oct       Impact factor: 5.606

5.  Bone mineral density in the femoral neck increases after hip resurfacing: a cohort with five-year follow-up.

Authors:  Charles A Willis-Owen; Henry D Atkinson; Roger D Oakeshott
Journal:  Int Orthop       Date:  2010-08-22       Impact factor: 3.075

Review 6.  Osteoporosis in pregnancy.

Authors:  W Khovidhunkit; S Epstein
Journal:  Osteoporos Int       Date:  1996       Impact factor: 4.507

7.  Dual-energy X-ray absorptiometry in normal women: a cross-sectional study of 717 Finnish volunteers.

Authors:  H Kröger; J Heikkinen; K Laitinen; A Kotaniemi
Journal:  Osteoporos Int       Date:  1992-05       Impact factor: 4.507

8.  Contributions of chronological age, age at menarche and menopause and of anthropometric parameters to axial and peripheral bone densities.

Authors:  L Vico; B Prallet; D Chappard; B Pallot-Prades; R Pupier; C Alexandre
Journal:  Osteoporos Int       Date:  1992-05       Impact factor: 4.507

9.  An evaluation of dual-energy X-ray absorptiometry and comparison with dual-photon absorptiometry.

Authors:  B Lees; J C Stevenson
Journal:  Osteoporos Int       Date:  1992-05       Impact factor: 4.507

10.  Peak bone mass and osteoporosis prevention.

Authors:  J A Eisman; P J Kelly; N A Morrison; N A Pocock; R Yeoman; J Birmingham; P N Sambrook
Journal:  Osteoporos Int       Date:  1993       Impact factor: 4.507

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.